免疫抑制剂的不精确性:对新陈代谢和微生物群的多方向影响
Allison Kensiski1, Samuel J Gavzy1,2, Long Wu1
1Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Clinical microbiology reviews
|March 5, 2025
概括
免疫抑制剂可以防止移植排斥,但会损害肠道微生物群和新陈代谢. 了解这些非目标效应是改善移植结果和移植存活的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 代谢科学 代谢科学
背景情况:
- 移植接受者需要终身免疫抑制以防止器官排斥.
- 目前的免疫抑制剂缺乏抗原特异性,导致慢性炎症,痕和移植失败.
- 这些药物也会导致肠道失调和代谢障碍.
研究的目的:
- 审查免疫抑制剂治疗对非免疫性,肠道微生物组和新陈代谢的影响.
- 为了强调对代谢障碍的具体影响.
- 为了识别与不同类型的免疫抑制剂相关的微生物和代谢特征.
主要方法:
- 关于免疫抑制作用的文献综述.
- 对非免疫性,肠道微生物组和宿主新陈代谢的影响分析.
- 药物特异性微生物和代谢特征的表征.
主要成果:
- 免疫抑制剂广泛影响免疫力,肠道微生物群和新陈代谢.
- 不同的微生物和代谢特征与不同的免疫抑制剂类别有关.
- 这些影响有助于代谢障碍和潜在的移植功能障碍.
结论:
- 全面了解免疫抑制剂的目标和非目标作用至关重要.
- 准肠道微生物群和宿主代谢可能会优化免疫抑制疗法.
- 这种方法可以提高免疫抑制的有效性,移植的接受度和患者的存活率.
更多相关视频
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Factors Affecting Drug Biotransformation: Biological
128
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
128
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Factors Influencing Drug Absorption: Disease States and Pharmacology
471
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
471
Factors Affecting the Risk of Infection
11.5K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.5K
Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124


